- Home
- FG vs APGE Comparison
FG vs APGE Comparison
Compare FG & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FG | APGE |
|---|---|---|
| Founded | 1959 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.7B |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | FG | APGE |
|---|---|---|
| Price | $31.37 | $77.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $41.00 | ★ $99.44 |
| AVG Volume (30 Days) | 262.2K | ★ 941.6K |
| Earning Date | 11-06-2025 | 11-10-2025 |
| Dividend Yield | ★ 3.20% | N/A |
| EPS Growth | ★ 3428.12 | N/A |
| EPS | ★ 3.42 | N/A |
| Revenue | ★ $5,559,000,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.46 | N/A |
| P/E Ratio | $9.12 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $28.70 | $26.20 |
| 52 Week High | $47.76 | $80.99 |
Technical Indicators
Market Signals| Indicator | FG | APGE |
|---|---|---|
| Relative Strength Index (RSI) | 44.35 | 67.49 |
| Support Level | $30.45 | $73.55 |
| Resistance Level | $35.33 | $80.44 |
| Average True Range (ATR) | 1.13 | 3.14 |
| MACD | -0.39 | -0.47 |
| Stochastic Oscillator | 23.57 | 72.26 |
Price Performance
Historical ComparisonAbout FG F&G Annuities & Life Inc.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.